German–Soviet Commercial Agreement (1940)

Halfords receives investment in its Avayler software business as Bridgestone takes a 5% stake

Retrieved on:

Wednesday, November 1, 2023

ETA, LAS, Software as a service, App Store (iOS/iPadOS), Software, Growth, Commercial, SEMA, Algorithm, German–Soviet Commercial Agreement (1940), Satellite navigation device, Bridgestone, Halfords, Central Europe

In addition, the Commercial Agreement will allow Bridgestone to leverage Avayler's products in retail stores and mobile applications.

Key Points:

In addition, the Commercial Agreement will allow Bridgestone to leverage Avayler's products in retail stores and mobile applications.
The Avayler SaaS solution was developed in-house by Halfords to manage automotive services across its expansive garage network and increasing number of mobile vans.
"The Bridgestone investment in Avayler is an important endorsement by one of the world's largest automotive businesses.
"As well as becoming a shareholder in Avayler, Bridgestone will also deploy Avayler solutions to support its own mobility solutions and applications for drivers, fleet managers, and vehicle owners."

Halfords receives investment in its Avayler software business as Bridgestone takes a 5% stake

Retrieved on:

Wednesday, November 1, 2023

In addition, the Commercial Agreement will allow Bridgestone to leverage Avayler's products in retail stores and mobile applications.

Key Points:

In addition, the Commercial Agreement will allow Bridgestone to leverage Avayler's products in retail stores and mobile applications.
The Avayler SaaS solution was developed in-house by Halfords to manage automotive services across its expansive garage network and increasing number of mobile vans.
"The Bridgestone investment in Avayler is an important endorsement by one of the world's largest automotive businesses.
"As well as becoming a shareholder in Avayler, Bridgestone will also deploy Avayler solutions to support its own mobility solutions and applications for drivers, fleet managers, and vehicle owners."

SUMITOMO CORPORATION AND SMX ENTER COMMERCIAL AGREEMENT

Retrieved on:

Wednesday, March 8, 2023

Non-ferrous metal, Software, ID, Corporation, Commercial, US, German–Soviet Commercial Agreement (1940), Sumitomo Corporation, Metal, Partnership, Agreement, Extreme metal, Sogo, London, Recycling, Security printing, SMX, Sumitomo Group

NEW YORK, March 8, 2023 /PRNewswire/ -- SMX (Security Matters) Public Limited Company (Nasdaq: SMX; SMXWW), a company focused on digitising physical objects on the blockchain to enable a circular and closed loop economy, today announced that it has entered into an exclusive Commercial Agreement with Sumitomo Corporation, one of the world's leading general trading companies (Sogo shosha), for the exclusive, worldwide distribution to market and sell products for application in the Non-Ferrous Metals Market (all raw materials supply chain market segments of the Non-Ferrous Metals) as well as SMX's exclusive, worldwide reseller and sub licensor of the SMX's productsi and servicesii with respect to Customersiii in the Non-Ferrous Metals Market. SMX in turn has agreed to not directly or indirectly, market or sell products or provide SMX products or service to customers or for application in the Non-Ferrous Metals Market during the term of this Commercial Agreement other than through Sumitomo, unless otherwise agreed.

Key Points:

Sumitomo Corporation to contribute to scale SMX's marker technology with stakeholders and organisations within the Non-Ferrous Metals Market.
SMX in turn has agreed to not directly or indirectly, market or sell products or provide SMX products or service to customers or for application in the Non-Ferrous Metals Market during the term of this Commercial Agreement other than through Sumitomo, unless otherwise agreed.
"Sumitomo Corporation is thrilled to pursue the collaboration globally in the Non-Ferrous Metals market with SMX by utilizing its unique technology.
"We are honored to be working collaboratively with Sumitomo, to help achieve a more sustainable and ethical world for Non-Ferrous Metals.

Myovant Sciences Announces Corporate Updates and Financial Results for Third Fiscal Quarter 2022

Retrieved on:

Thursday, January 26, 2023

Third fiscal quarter 2022 net product revenues for ORGOVYX in the U.S. were $48.7 million, reflecting 12% sequential growth compared to the second fiscal quarter 2022.

Key Points:

Third fiscal quarter 2022 net product revenues for ORGOVYX in the U.S. were $48.7 million, reflecting 12% sequential growth compared to the second fiscal quarter 2022.
Approximately 4,000 new patients started treatment with ORGOVYX in the third fiscal quarter of 2022, reaching approximately 26,000 cumulative patients since launch.
In December 2022, Myovant completed a New Drug Submission to Health Canada seeking marketing approval for ORGOVYX for advanced prostate cancer.
Third fiscal quarter 2022 net product revenues for MYFEMBREE in the U.S. were $10.5 million, reflecting 64% sequential growth compared to second fiscal quarter 2022.

Evaxion and ExpreS²ion initiate research collaboration on a novel cytomegalovirus (CMV) vaccine candidate

Retrieved on:

Tuesday, December 6, 2022

During the discovery phase of the collaboration, Evaxion will use its proprietary AI platform, RAVEN, to design a next-generation vaccine candidate that elicits both cellular and humoral/antibody responses.

Key Points:

During the discovery phase of the collaboration, Evaxion will use its proprietary AI platform, RAVEN, to design a next-generation vaccine candidate that elicits both cellular and humoral/antibody responses.
Under the terms of the collaboration, ExpreS2ion will have the exclusive right to license the CMV vaccine candidate under a potential Development and Commercialization Agreement.
The research and intellectual property licensing costs for the collaboration project will be divided 50/50 between the parties until 2025, with all costs expected to be contained in each party’s existing operating expenses.
Since 2010, the Company has produced more than 500 proteins and virus-like particles (VLPs) in collaboration with leading research institutions and companies.

HEXO Completes Transactions With Tilray Brands, Creating a Strategic Alliance Between Two Canadian Cannabis Leaders

Retrieved on:

Tuesday, July 12, 2022

GATINEAU, Quebec, July 12, 2022 (GLOBE NEWSWIRE) -- HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the “Company"), a leading producer of high-quality cannabis products, is pleased to announce that the Company has closed its previously announced transaction with Tilray Brands, Inc. (“Tilray Brands”) (Nasdaq | TSX: TLRY).

Key Points:

This partnership with Tilray Brands is a game-changer for HEXO, said Charlie Bowman, CEO of HEXO Corp.
This is a unique opportunity to realize our vision of building Canadas leading cannabis alliance, noted Irwin D. Simon, Chairman and CEO of Tilray Brands.
HEXO and Tilray Brands have also entered into certain commercial agreements, providing the two companies with cost saving synergies and production efficiencies (the Commercial Agreements).
Operational Flexibility: The Amended Note provides HEXO with immediate operational flexibility by modifying the terms to be more favourable to HEXO.

Tilray Brands Announces Enhancements to Accretive Strategic Transaction with HEXO

Retrieved on:

Tuesday, June 14, 2022

LEAMINGTON, Ontario, June 14, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray Brands” or the “Company”) (Nasdaq | TSX: TLRY) today announced that the Company has entered into amendments to improve the terms of its previously-disclosed agreements to acquire all of the outstanding principal, plus accrued and unpaid interest, under a secured convertible note (the “HEXO Note”) issued by HEXO Corp. (“HEXO”) to HT Investments MA LLC (“HTI”). These amendments provide for, among other things, an additional discount to Tilray Brands’ purchase price as well as the reduction of the conversion price under the HEXO Note from CAD$0.85 to CAD$0.40 per share.

Key Points:

As previously announced, the strategic alliance between Tilray Brands and HEXO is expected to provide several financial and commercial benefits, including:
Substantial Synergies: the strategic alliance between Tilray Brands and HEXO is expected to deliver up to $80 million of shared cost-saving synergies within two years of the completion of the Transaction.
Accretion: as a result of the substantial synergies, the acquisition of the HEXO Note by Tilray Brands will be immediately accretive to the Company.
As consideration for Tilray Brands acquisition of the HEXO Note, Tilray Brands will pay 89.2% of the then outstanding principal balance for the HEXO Note (the Purchase Price).
HEXO will not receive any proceeds as a result of Tilray Brands proposed purchase of the HEXO Note from HTI.

HEXO Enters Into Definitive Agreement With Tilray Brands to Create a Strategic Alliance Between Two Canadian Cannabis Leaders

Retrieved on:

Tuesday, April 12, 2022

GATINEAU, Quebec, April 12, 2022 (GLOBE NEWSWIRE) -- HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the “Company"), a leading producer of high-quality cannabis products, today announced that the Company has taken a significant step forward in executing on its strategic plan - The Path Forward - by entering into definitive agreements with Tilray Brands, Inc. (“Tilray Brands”) (Nasdaq | TSX: TLRY), as well as entering into a definitive equity purchase agreement (the “Standby Agreement”) with an affiliate of KAOS Capital Inc. (the “Standby Party”), further to the Company’s press release of March 3, 2022. Closing of the transaction with Tilray Brands and the Standby Agreement is expected to occur by the end of May 2022, subject to the satisfaction or waiver of closing conditions.

Key Points:

Its an ideal outcome and one were exceptionally pleased with, said Mark Attanasio, Executive Chairman of the Board of Directors of HEXO.
This strategic investment in HEXO is a strong vote of confidence in the Companys newly focused growth strategy, noted Adam Arviv, CEO of KAOS Capital.
Operational Flexibility: The Amended Note will provide HEXO with immediate operational flexibility by modifying the terms to be more favourable to HEXO.
The Transaction Agreement also provides for the payment by HEXO to Tilray Brands of a termination fee in certain circumstances.

Opioid Receptor Agonists Pipeline Research Report 2022: Insights on 40+ Companies and 40+ Pipeline Drugs - ResearchAndMarkets.com

Retrieved on:

Thursday, February 3, 2022

This "Opioid Receptor Agonists - Pipeline Insight, 2022" report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in Opioid Receptor Agonists pipeline landscape.

Key Points:

This "Opioid Receptor Agonists - Pipeline Insight, 2022" report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in Opioid Receptor Agonists pipeline landscape.
The companies and academics are working to assess challenges and seek opportunities that could influence Opioid Receptor Agonists R&D.
This segment of the Opioid Receptor Agonists report encloses its detailed analysis of various drugs in different stages of clinical development, including phase II, I, preclinical and Discovery.
This segment of the report provides insights about the different Opioid Receptor Agonists drugs segregated based on following parameters that define the scope of the report.

Affinor Growers Signs Commercialization Agreement With Britespan Building Systems for New Polycarbonate Greenhouse Structure

Retrieved on:

Tuesday, November 30, 2021

VANCOUVER, British Columbia, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Affinor Growers Inc. (Affinor or the Company) (CSE: AFI; OTCQB: RSSFF) is pleased to announce it has signed a commercialization agreement dated November 29, 2021 (the Commercialization Agreement) with Britespan Building Systems Inc. (Britespan), a private Ontario Corporation, to engineer and manufacture new polycarbonate greenhouses co-designed by Affinor and Britespan.

Key Points:

VANCOUVER, British Columbia, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Affinor Growers Inc. (Affinor or the Company) (CSE: AFI; OTCQB: RSSFF) is pleased to announce it has signed a commercialization agreement dated November 29, 2021 (the Commercialization Agreement) with Britespan Building Systems Inc. (Britespan), a private Ontario Corporation, to engineer and manufacture new polycarbonate greenhouses co-designed by Affinor and Britespan.
Affinor conceived the Atlantis greenhouse (the Atlantis Greenhouse) by adding a polycarbonate material to the outside surface of the Britespan building trusses, dramatically improving certain key performance characteristics of commercial greenhouse systems.
Pursuant to the terms and conditions of the Commercialization Agreement, Affinor will be the exclusive worldwide dealer of the Atlantis Greenhouse and Britespan will be the exclusive worldwide supplier of the Atlantis Greenhouse Structure for a term of ten years, with automatic 2-year renewals thereafter.
Affinor and Britespan have joint right, title and interest in the Atlantis Greenhouse, including any enhancements, changes or improvements introduced by either party.